Clinical Trials Browser

Phase 1/2 × Withdrawn × Lapatinib × Clear all

NCT00455039 2023-08-14

INST 0514C- Biologic Correlative Study: Trial of GW572016 in HER2 Overexpressing Breast Cancer Patients

Phase 1/2 Withdrawn

Breast Neoplasms